Bausch Health
BHC
$8.71
Share price
1.04%
Change (1 day)
22.33%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
P/S ratio for Bausch Health (BHC)
P/S ratio as of April 2024 (TTM): 0.3887
According to Bausch Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.388718. At the end of 2023 the company had a P/S ratio of 0.3538.
P/S ratio history for Bausch Health from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.3538 | 25.97% |
| 2022 | 0.2808 | -75.95% |
| 2021 | 1.17 | 27.41% |
| 2020 | 0.9164 | -24.87% |
| 2019 | 1.22 | 57.59% |
| 2018 | 0.7740 | -7.09% |
| 2017 | 0.8330 | 60.51% |
| 2016 | 0.5190 | -84.42% |
| 2015 | 3.33 | -42.54% |
| 2014 | 5.80 | -14.17% |
| 2013 | 6.76 | 32.2% |
| 2012 | 5.11 | -12.42% |
| 2011 | 5.84 | -19.4% |
| 2010 | 7.24 | 167.62% |
| 2009 | 2.71 | 37% |
| 2008 | 1.97 | -23.21% |
| 2007 | 2.57 | -19.58% |
| 2006 | 3.20 | -20.91% |
| 2005 | 4.04 | 35.71% |
| 2004 | 2.98 | -28.1% |
| 2003 | 4.14 | -21.82% |
| 2002 | 5.30 | -65.11% |
| 2001 | 15.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.02 | 161.64% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 23,695.81% | 🇺🇸 USA |